The Competition Commission of India (CCI) approves merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for the acquisition of approximately 15% equity shareholding of Biocon Biologics by Serum Institute Life Sciences.@CCI_India pic.twitter.com/O2TIsEfcKa— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) May 19, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


